These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 1449103)

  • 21. Sustained effect of and lack of development of tolerance to controlled-release isosorbide-5-mononitrate in chronic stable angina pectoris.
    Wisenberg G; Roks C; Nichol P; Goddard MD
    Am J Cardiol; 1989 Sep; 64(10):569-76. PubMed ID: 2782247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitrate tolerance.
    Parker JO
    Am J Cardiol; 1985 Dec; 56(17):28I-31I. PubMed ID: 3934952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the effects of a controlled-release formulation of isosorbide-5-mononitrate and conventional isosorbide dinitrate on exercise performance in men with stable angina pectoris.
    Seabra-Gomes R; Aleixo AM; Adao M; Machado FP; Mendes M; Bruges G; Palos JL
    Am J Cardiol; 1990 Jun; 65(20):1308-12. PubMed ID: 2188493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. When does nitrate tolerance develop? What dosages and which intervals are necessary to ensure maintained effectiveness?
    Rudolph W; Dirschinger J; Reiniger G; Beyerle A; Hall D
    Eur Heart J; 1988 Jan; 9 Suppl A():63-72. PubMed ID: 3137072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The rationale for nitrates in angina pectoris.
    Held P; Olsson G
    Can J Cardiol; 1995 Apr; 11 Suppl B():11B-13B. PubMed ID: 7728648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of 50-mg and 100-mg sustained-release isosorbide mononitrate in the treatment of stable angina pectoris: effects on quality-of-life indices. Dutch Mononitrate Quality of Life (DUMQOL) Study Group.
    Zwinderman AH; Cleophas TJ; van der Sluijs H; Niemeyer MG; Buunk BP; van der Wall EE
    Angiology; 1999 Dec; 50(12):963-9. PubMed ID: 10609762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitrate therapy for stable angina pectoris.
    Parker JD; Parker JO
    N Engl J Med; 1998 Feb; 338(8):520-31. PubMed ID: 9468470
    [No Abstract]   [Full Text] [Related]  

  • 28. Long-acting isosorbide mononitrate.
    Prakash A; Markham A
    Drugs; 1999 Jan; 57(1):93-9; discussion 100. PubMed ID: 9951954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of twice-daily isosorbide-5-mononitrate in preventing development of tolerance in angina pectoris.
    Thadani U; Prasad R; Hamilton SF; Voyles W; Doyle R; Karpow S; Reder R; Teague SM
    Am J Cardiol; 1987 Sep; 60(7):477-82. PubMed ID: 3630929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
    Parker JO
    Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nitrate tolerance. How to prevent it or minimize its effect.
    Thadani U
    Postgrad Med; 1992 Apr; 91(5):307-12, 315-8. PubMed ID: 1561169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of 8:00 a.m. and 2:00 p.m. doses of isosorbide-5-mononitrate during twice-daily therapy in stable angina pectoris.
    Thadani U; Bittar N
    Am J Cardiol; 1992 Aug; 70(3):286-92. PubMed ID: 1632390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate].
    Kośmicki M; Szwed H; Kowalik I; Sadowski Z
    Pol Merkur Lekarski; 2002 Jul; 13(73):52-5. PubMed ID: 12362508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abrupt withdrawal of isosorbide 5-mononitrate (Imdur) after long term treatment in stable angina pectoris. A preliminary report.
    Rehnqvist N; Olsson G; Engvall J; Rosenqvist U; Nyberg G; Aberg A; Ulvenstam G; Uusitalo A; Keyriläinen O; Härkönen R
    Drugs; 1987; 33 Suppl 4():118-21. PubMed ID: 2887419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isosorbide-5-mononitrate in angina pectoris.
    Poss M; Racicot D; Kiser WR
    Ann Intern Med; 1994 Oct; 121(7):547. PubMed ID: 8093205
    [No Abstract]   [Full Text] [Related]  

  • 36. Lack of effect of asymmetrical dosage timing of isosorbide-5-mononitrate on nitrate tolerance during long-term administration.
    Hughes LO; DasGupta P; Jain D; Lahiri A; Raftery EB
    Eur J Clin Pharmacol; 1989; 36(2):139-44. PubMed ID: 2498105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Long-term therapy with nitrates. How can continuous effectiveness be achieved?].
    Rudolph W; Dirschinger J; Reiniger G; Beyerle A
    Fortschr Med; 1989 Jun; 107(19):41-2, 45-7. PubMed ID: 2668139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abrupt withdrawal of isosorbide-5-mononitrate in Durules (Imdur) after long term treatment in patients with stable angina pectoris.
    Rehnqvist N; Olsson G; Engvall J; Rosenqvist U; Nyberg G; Aberg A; Ulvenstam G; Uusitalo A; Keyriläinen O; Reinikainen P
    Eur Heart J; 1988 Dec; 9(12):1339-47. PubMed ID: 3147892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sustained hemodynamic and antianginal effects of high dose oral isosorbide dinitrate.
    Aronow S
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2483-6. PubMed ID: 7422537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative study of retard and non-retard forms of isosorbide-5-mononitrate in coronary patients with stable angina pectoris].
    Lupanov VP; Alekseeva IA; Vasil'eva NN; Romasiuk SS; Afanas'eva IuV; Naumov VG
    Klin Med (Mosk); 2000; 78(11):36-8. PubMed ID: 11232528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.